找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiotherapy in Skin Cancer; A Practical Guide on Kurian Jones Joseph,Michael J. Veness,Agata Rembie Book 2023 The Editor(s) (if applicable

[復(fù)制鏈接]
樓主: Concave
21#
發(fā)表于 2025-3-25 06:28:26 | 只看該作者
22#
發(fā)表于 2025-3-25 09:43:00 | 只看該作者
Lipry and primary radical radiotherapy are equal treatment modalities for early-stage carcinomas; adjuvant radiotherapy improves outcomes for those with lip carcinomas with high-risk features..The evidence base lacks prospective data on patient-reported outcome measures and quality-of-life metrics; dat
23#
發(fā)表于 2025-3-25 15:08:48 | 只看該作者
Ear ear is a high-risk region for locoregional recurrence. Treatment planning can be challenging given the irregular surface contours of the ear. Treatment may be delivered with kilovoltage, electrons, photons, and brachytherapy depending on the site of disease presentation.
24#
發(fā)表于 2025-3-25 18:41:12 | 只看該作者
25#
發(fā)表于 2025-3-25 20:40:00 | 只看該作者
Primary Melanoma and Lentigo Maligna after complete excision of a primary melanoma to reduce local recurrence based on certain pathological indications. RT is rarely used as the primary treatment for certain patients with unresectable primary melanoma after multidisciplinary team discussion. For lentigo maligna, RT is an acceptable no
26#
發(fā)表于 2025-3-26 00:08:26 | 只看該作者
Merkel Cell Carcinomaere on the body, and most (50–60%) patients present with a primary lesion with the incidence of subclinical nodal spread high (30–50%). There is an extensive body of evidence supporting the addition of adjuvant radiotherapy in improving locoregional control and survival. Patients are often not suita
27#
發(fā)表于 2025-3-26 07:49:57 | 只看該作者
28#
發(fā)表于 2025-3-26 11:58:38 | 只看該作者
Regional Radiotherapy in Head and Neck Non-melanoma Skin Cancernd neck region. Optimal management of NMSC with metastatic regional disease involves surgery and adjuvant radiotherapy (RT). Elective nodal RT may occasionally be considered in select cases with a high-risk primary character. The addition of chemotherapy to RT in locoregionally advanced cutaneous sq
29#
發(fā)表于 2025-3-26 13:22:43 | 只看該作者
30#
發(fā)表于 2025-3-26 19:30:50 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 22:12
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
东乌珠穆沁旗| 天台县| 弥渡县| 兴义市| 巴南区| 莱芜市| 安福县| 桦南县| 九龙坡区| 博爱县| 呼和浩特市| 万年县| 嘉峪关市| 徐汇区| 梧州市| 东乌珠穆沁旗| 鹿泉市| 芦山县| 永新县| 都江堰市| 上虞市| 永平县| 白水县| 泰州市| 马山县| 安龙县| 深水埗区| 潮州市| 合阳县| 曲水县| 枣强县| 海伦市| 双辽市| 沂水县| 盐城市| 巩义市| 福泉市| 蒙自县| 姚安县| 道孚县| 柞水县|